Yazmin Odia, MD, MS, FAAN, a Neuro-Oncologist at Miami Cancer Institute, part of Baptist Health South Florida
Get to know Neuro-Oncologist Dr. Yazmin Odia, who serves patients in Miami, Florida.
Dr. Odia is the Chief of Neuro-Oncology at Miami Cancer Institute (MCI) part of Baptist Health South Florida. She also serves on the Scientific Review Committee at MCI and the Medical Executive Committee at Baptist Hospital.
She further rounds out the Institute’s highly specialized and comprehensive brain tumor program, providing the southern two-thirds of the state, Latin America, and the Caribbean access to expert neuro-oncology care. She also collaborates with clinical experts across the organization to provide treatment to patients with malignant and benign tumors of the nervous system, including primary and metastatic brain and spine cancers. She conducts local, regional, and national clinical trials that hopefully bring significant advances in neuro-oncology cancer care to patients in South Florida, the Caribbean, and beyond.
Prior to joining Miami Cancer Institute, she was an assistant professor of neurology at Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital.
A Chicago Honor Scholar, Dr. Odia received her Bachelor of Arts degree and medical degree from the University of Chicago. She received a Master of Science degree in Clinical Research at Mayo Clinic in Rochester, Minnesota. She then completed an internship in internal medicine at Johns Hopkins Bayview Medical Center, a residency in neurology at Johns Hopkins Hospital, and a clinical and research fellowship in the Neuro-Oncology Branch of the National Institutes of Health in Bethesda, Maryland.
An expert in her field, the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology. She is also board-certified in neuro-oncology by the United Council for Neurologic Subspecialties (UCNS). The UCNS is a not-for-profit corporation that formally recognizes emerging neurologic subspecialties.
A Fellow of the American Academy of Neurology (FAAN), Dr. Odia serves as Chair of the Diversity Leadership Subcommittee and member of the Leadership Development Committee, Health Care Disparities Task Force, Spanish Language Work Group, and Undergraduate Education Subcommittee. She is also a member of the American Society of Clinical Oncology and Society for Neuro-Oncology.
Her honors include Columbia University/New York Presbyterian Hospital’s Stephen Q. Shafer Award for Humanism in Neurology and John Hopkins’ Guy M. McKhann Award for Teaching and Communication Excellence. She also received the Top Doctor Awards in New York City (2015-2016) and Miami (2018-2021) and was named a US Castle Connolly Top Doctor (2019).
Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worst. Neuro-oncologists are neurologists who specialize in diagnosing and treating brain and nervous system cancers and administering chemotherapy to patients.
On a more personal note, Dr. Odia speaks both English and Spanish.
Learn More about Dr. Yazmin Odia:
Through her findatopdoc profile, https://www.findatopdoc.com/doctor/2658934-Yazmin-Odia-Neurologist or through Baptist Health South Florida, https://doctors.baptisthealth.net/provider/Yazmin+Odia/868449 .
A list of her scientific publications can be found at https://www.ncbi.nlm.nih.gov/myncbi/1-oZkHgFDBNA8/bibliography/public/.
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know how to make informed decisions for you and your family.
